Strides Pharma Science Limited founder and managing director Arun Kumar said he does not see a “constraining situation” for supplies of active pharmaceutical ingredients (API) to manufacture a generic to Amarin Corporation plc’s only commercialized product to date Vascepa (icosapent ethyl).
US marketing partner Amneal Pharmaceuticals, Inc
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?